Unknown

Dataset Information

Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy.


ABSTRACT:

Objective

The main goal of this work was to identify, describe, characterize, and classify the scientific evidence regarding the use of pharmacogenomic biomarkers in antidepressant treatment.

Methods

The work was developed in two phases: i) a search for pharmacogenomic biomarkers in summaries of antidepressant drugs with marketing authorization in Portugal; and ii) a systematic literature review based on the data obtained in the first phase, with the main objective of finding international literature that could describe and characterize previously reported biomarkers and identify other relevant biomarkers. Finally, the levels of evidence and recommendation grades were classified.

Results

Among the 26 drugs with marketing authorization in Portugal, only 16 had pharmaco

SUBMITTER: Correia C 

PROVIDER: S-EPMC9425945 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature